Personal information

Activities

Collapse all

Employment (5)

Arthritis Research UK: Milton Keynes, GB

2012 to present | Director (Experimental Osteoarthritis Treatment Centre)
Employment
Source: Self-asserted source
Philip Conaghan

NIHR Leeds Biomedical Research Centre: Leeds, Leeds, GB

2008 to present | Deputy Director (Rheumatology)
Employment
Source: Self-asserted source
Philip Conaghan

University of Leeds School of Medicine: Leeds, Leeds, GB

2005 to present | Professor of Musculoskeletal Medicine (Institute of Rheumatic and Musculoskeletal Medicine)
Employment
Source: Self-asserted source
Philip Conaghan

Leeds Community Healthcare NHS Trust: Leeds, Leeds, GB

2003 to present | Honorary Consultant (Rheumatology)
Employment
Source: Self-asserted source
Philip Conaghan

Leeds Teaching Hospitals NHS Trust: Leeds, Leeds, GB

2001 to present | Honorary Consultant Rheumatologist (Rheumatology)
Employment
Source: Self-asserted source
Philip Conaghan

Education and qualifications (6)

General Medical Council: London, London, GB

GMC Registration number 4390776 (UK Specialist Registration: General Medicine & Rheumatology)
Education
Source: Self-asserted source
Philip Conaghan

University of New South Wales: Sydney, NSW, AU

2005 | Doctor of Philosophy
Education
Source: Self-asserted source
Philip Conaghan

Royal College of Physicians: London, London, GB

2004 | Fellowship number 119301
Education
Source: Self-asserted source
Philip Conaghan

Fellow of the Royal Australasian College of Physicians: Sydney, NSW, AU

1992 | Fellowship number 5939
Education
Source: Self-asserted source
Philip Conaghan

Royal College of Pathologists of Australasia: NSW, NSW, AU

1987 | Part 1 (Special Haematology)
Education
Source: Self-asserted source
Philip Conaghan

University of Melbourne: Melbourne, VIC, AU

1983 | Bachelor of Medicine, Bachelor of Surgery
Education
Source: Self-asserted source
Philip Conaghan

Funding (31)

Removing barriers to inclusion and building strong foundations of partnership and trust with under-served groups

2023-03 to 2023-08 | Grant
NIHR Programme Development Grant (Leeds, GB)
Source: Self-asserted source
Philip Conaghan

Arthritis, work and wellbeing: A mixed methods study with policy recommendations

2023-01 to 2026-01 | Grant
Nuffield - Oliver Bird (and Versus Arthritis) (London, GB)
Source: Self-asserted source
Philip Conaghan

NIHR Leeds Biomedical Research Centre

2022-12 to 2026-12 | Grant
NIHR Biomedical Research Centre (Leeds, GB)
Source: Self-asserted source
Philip Conaghan

Steroid-Reducing Options for ReLapsING PMR (STERLING-PMR): a pragmatic, randomised trial to compare the clinical and cost-effectiveness of adding immunosuppression to steroid-tapering treatment for patients with relapsing PMR, versus steroid-tapering alone

2022-01 to 2026-12 | Grant
NIHR BioResource (Leeds, GB)
Source: Self-asserted source
Philip Conaghan

Immuno Diagnostix (IDX) - An ultrasensitive, low cost photonic biosensor

2021-08 to 2024-08 | Grant
Engineering and Physical Sciences Research Council (Swindon, England, GB)
Source: Self-asserted source
Philip Conaghan

Development and evaluation of the Digital-My Arm Pain Programme (D-MAPP) for improving painful distal upper limb musculoskeletal disorders

2021-07-01 to 2027-06-30 | Grant
National Institute for Health Research (London, GB)
URL: https://app.dimensions.ai/details/grant/grant.9959558
GRANT_NUMBER: NIHR201612
Source: Self-asserted source
Philip Conaghan via DimensionsWizard

Synovial fluid to define molecular endotypes by unbiased proteomics in OA (STEpUP-OA)

2019-01 to 2022-01 | Grant
Versus Arthritis (Chesterfield, GB)
Source: Self-asserted source
Philip Conaghan

BRC MRI Scanner Equipment

2019-01 to 2021-06 | Grant
Leeds Cares (Leeds, GB)
Source: Self-asserted source
Philip Conaghan

Inequalities in socioeconomic outcomes for people living with arthritis

2019-01 to 2021-01 | Grant
Nuffield - Oliver Bird (London, GB)
Source: Self-asserted source
Philip Conaghan

Evaluation and implementation of electronic-rehabilitation programmes for chronic knee pain in the UK

2018-01 to 2020-10 | Grant
Versus Arthritis (Chesterfield, GB)
Source: Self-asserted source
Philip Conaghan

A dietary intervention trial to examine the protective effect of broccoli bioactives (specifically sulforaphane) on osteoarthritis

2018-01 to 2020-01 | Grant
Versus Arthritis (Chesterfield, GB)
Source: Self-asserted source
Philip Conaghan

Centre for Sport, Exercise and Osteoarthritis

2017-01 to 2022-01 | Grant
Arthritis Research UK (Milton Keynes, GB)
Source: Self-asserted source
Philip Conaghan

Osteoarthritis Preoperative Package of care of Orthotics, Rehabilitation, Topical and oral agent Usage and Nutrition to Improve outcomes at a Year (OPPORTUNITY).

2017 to 2019 | Grant
Arthritis Research UK (Milton Keynes, GB)
Source: Self-asserted source
Philip Conaghan

Developing peer Mentorship to Improve self-management of Osteoarthritis: A feasibility study (aMIgO study)

2016-01 to 2019-01 | Grant
Research for Patient Benefit Programme (Leeds, GB)
Source: Self-asserted source
Philip Conaghan

Leeds Musculoskeletal Biomedical Research Centre

2016 to 2021 | Grant
National Institute for Health Research (Leeds, GB)
Source: Self-asserted source
Philip Conaghan

Novel design analysis tools to increase precision and reduce variation in hip replacement performance

2016 to 2021 | Contract
Engineering and Physical Sciences Research Council (Swindon, GB)
Source: Self-asserted source
Philip Conaghan

Optimising knee therapies through improved population stratification and precision of the intervention.

2016 to 2021 | Grant
Engineering and Physical Sciences Research Council (Swindon, GB)
Source: Self-asserted source
Philip Conaghan

Is ultrasound stratification informative for shoulder pain management

2016 to 2019 | Contract
National Institute for Health Research (Leeds, GB)
Source: Self-asserted source
Philip Conaghan

Towards UK poSt Arthroplasty Follow-up rEcommendations: UK SAFE.

2016 to 2019 | Grant
National Institute for Health Research (Leeds, GB)
Source: Self-asserted source
Philip Conaghan

Osteoarthritis Technology NetworkPlus (OATech+): a multidisciplinary approach to the prevention and treatment of osteoarthritis

2016 to 2018 | Grant
Engineering and Physical Sciences Research Council (Swindon, GB)
Source: Self-asserted source
Philip Conaghan

Providing a standardised approach to virtual clinic follow-up of total joint replacement

2016 to 2018 | Grant
Arthritis Research UK (Milton Keynes, GB)
Source: Self-asserted source
Philip Conaghan

Applied Public-Private Research enabling OsteoArthritis Clinical Headway (APPROACH)

2015 to 2021 | Grant
Innovative Medicines Initiative (Brussels, BE)
Source: Self-asserted source
Philip Conaghan

Chondroitin Sulphate for hand osteoarthritis: a randomised, placebo-controlled trial in primary care: The FACTUAL study

2015 to 2020 | Grant
National Institute for Health Research (Leeds, GB)
Source: Self-asserted source
Philip Conaghan

National Centre for Translational Hyperpolarised Magnetic Resonance

2014 to present | Grant
Medical Research Council (Swindon, GB)
Source: Self-asserted source
Philip Conaghan

The Partnership for Early Knee osteoarthritis definition through imaging and tissue biomarkers (PEARL-OA)

2014 to 2018 | Grant
Rheumatology Research Foundation (GA, GA, US)
Source: Self-asserted source
Philip Conaghan

Quantitative 3-dimensional assessment of multi-tissue pathology in knee osteoarthritis (ref 20800)

2014 to 2017 | Grant
Arthritis Research UK (Milton Keynes, GB)
Source: Self-asserted source
Philip Conaghan

Stratified interventions for patellofemoral pain using phenotyping based on MRI

2013 to 2017 | Grant
National Institute for Health Research (Leeds, GB)
Source: Self-asserted source
Philip Conaghan

PROMOTE: A pragmatic, double-blind, randomised, placebo-controlled trial of methotrexate to treat painful knee osteoarthritis. (ref 20186)

2012-01 to 2015-01 | Grant
Arthritis Research UK (Milton Keynes, GB)
Source: Self-asserted source
Philip Conaghan

Experimental Osteoarthritis Treatment Centre (ref 20083)

2012 to 2017 | Grant
Arthritis Research UK (Milton Keynes, GB)
Source: Self-asserted source
Philip Conaghan

Sports injury and osteoarthritis

2012 to 2017 | Grant
Arthritis Research UK (Milton Keynes, GB)
Source: Self-asserted source
Philip Conaghan

HERO: Hydroxychloroquine Effectiveness in Reducing symptoms of hand Osteoarthritis, a randomised, double-blind, placebo-controlled trial

2011-09-01 to 2015-04-30 | Grant
Versus Arthritis (Chesterfield, GB)
URL: https://app.dimensions.ai/details/grant/grant.5140674
GRANT_NUMBER: 19545
Source: Self-asserted source
Philip Conaghan via DimensionsWizard

Peer review (3 reviews for 3 publications/grants)

Review activity for Annals of the rheumatic diseases (1)
Review activity for Nature medicine. (1)
Review activity for RMD open. (1)
How many people are using ORCID?